N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer
Abstract Background: The N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) is the only writer responsible for DNA 6mA modifications. At present, its…